For this, we extensively profiled a series of primary fibroblast cells from AGS patients with mutations in AGS1, AGS2, and AGS4 and AGS5 using high-throughput sequencing technologies. This evidence concerns the gene RNASEH2B and Aicardi-Goutieres syndrome.